ES2044887T3 - Metodo para la preparacion de factor de crecimiento de tipo insulina i. - Google Patents

Metodo para la preparacion de factor de crecimiento de tipo insulina i.

Info

Publication number
ES2044887T3
ES2044887T3 ES87114733T ES87114733T ES2044887T3 ES 2044887 T3 ES2044887 T3 ES 2044887T3 ES 87114733 T ES87114733 T ES 87114733T ES 87114733 T ES87114733 T ES 87114733T ES 2044887 T3 ES2044887 T3 ES 2044887T3
Authority
ES
Spain
Prior art keywords
igf
preparation
growth factor
type growth
met
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87114733T
Other languages
English (en)
Spanish (es)
Inventor
Ueda Ikuo
Niwa Mineo
Saito Yoshimasa
Ishii Yoshinori
Kitaguchi Tadashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2044887T3 publication Critical patent/ES2044887T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES87114733T 1986-10-09 1987-10-08 Metodo para la preparacion de factor de crecimiento de tipo insulina i. Expired - Lifetime ES2044887T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24070286 1986-10-09

Publications (1)

Publication Number Publication Date
ES2044887T3 true ES2044887T3 (es) 1994-01-16

Family

ID=17063431

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87114733T Expired - Lifetime ES2044887T3 (es) 1986-10-09 1987-10-08 Metodo para la preparacion de factor de crecimiento de tipo insulina i.

Country Status (5)

Country Link
EP (1) EP0264074B1 (enExample)
AT (1) ATE84065T1 (enExample)
DE (1) DE3783305T2 (enExample)
ES (1) ES2044887T3 (enExample)
GR (1) GR3007491T3 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd ｈＥＧＦの製法
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
DE69133087T2 (de) * 1990-05-30 2003-04-03 Institute Of Molecular Biology Inc., Boston Kombination aus IGF-I und TGF-beta zur Knochenregenerierung
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
WO1996007744A1 (en) * 1994-09-08 1996-03-14 Chiron Corporation A method of improved production of insulin-like growth factor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
EP0440311A1 (en) * 1985-06-20 1991-08-07 Fujisawa Pharmaceutical Co., Ltd. A process for the production of alpha-human atrial natriuretic polypeptide

Also Published As

Publication number Publication date
ATE84065T1 (de) 1993-01-15
DE3783305T2 (de) 1993-05-19
DE3783305D1 (de) 1993-02-11
EP0264074A3 (en) 1989-10-25
GR3007491T3 (enExample) 1993-07-30
EP0264074B1 (en) 1992-12-30
EP0264074A2 (en) 1988-04-20

Similar Documents

Publication Publication Date Title
ATE107958T1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
EP0156355A3 (en) Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
FI102075B1 (fi) Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit
BG60053B2 (bg) Метод за повишаване способността за получаване на антибиотик
DK161152C (da) Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
FI104261B1 (fi) Menetelmä yhdistelmä ihmisen erytropoietiinin tuottamiseksi
DE3650055D1 (de) Fibroblast-wachstumsfaktor.
PT85349A (en) Method for the preparation of proteins with factor viii activity by microbial host cells expression vectors host cells antibodies
DE69229572D1 (de) Gliazellen-aktivierender Faktor und dessen Herstellung
ATE196162T1 (de) Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
ZA918462B (en) Expression system.
EP0200909A3 (en) Preparation of protein g and/or fragments thereof
PT90321A (pt) Processo para a preparacao de polipeptideos de veneno de vibora
AU7126487A (en) Production of proteins by cell culture
MY104910A (en) New derivatives of human/bovine4 basic fibroblast growth factor.
CA2011833A1 (en) Novel polypeptide and production thereof
EP0264074A3 (en) Expression vector for insulin-like growth factor i
GR3007031T3 (enExample)
NO175872C (no) Plasmidvektor, fremgangsmåte for fremstilling av peptider og myelomcelle
AU5309586A (en) Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms
DK502786A (da) Fremgangsmaade til fremstilling af en vaekstfaktor
DK181790D0 (da) Fermenteringsmedier og fremgangsmaader til regulering af norleucinindholdet i polypeptider
DE69130818D1 (de) Chondromodulin-I-Protein
DK171489A (da) Peptidderivater
SE8803567D0 (sv) Rekombinantisk, syntesen av maenniskofibroblast-beta1-interferon kodande plasmid-dnappr-ifnbeta-13, foerfarande foer konstruering av naemnda plasmid-dna och maennisko-beta1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika vl 903 (ppr-ifnbeta-13)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 264074

Country of ref document: ES